A new pain relief drug, suzetrigine, is a prescription pill that’s taken every 12 hours after a larger starter dose. It will ...

The FDA has approved Journavx, a new non-opioid pain medication designed to reduce addiction and overdose risks.

A new opioid-free pain medication was approved by the FDA on Thursday, marking a non-addictive alternative for patients.

After decades of research, Vertex Pharmaceuticals now has an approved pain medication. Can one of the world’s most powerful ...

Cannabidiol (CBD) holds promise as a treatment for many health concerns, including inflammation. For all the known benefits CBD offers, it’s unclear how well it can relieve nerve pain.

Four in every 10 cancer patients treated with chemotherapy develop severe peripheral nerve pain, a new review suggests.

Have you experienced pain or tingling in your hands or feet? Those are signs of possible neuropathy, “a general term for ...

Worldwide, cancer chemotherapy is linked to persistent severe peripheral nerve pain (neuropathy) for around 4 in every 10 patients treated with these drugs, suggests a pooled data analysis of the ...

Explore how chemotherapy causes peripheral neuropathy in 40% of cancer patients. Learn about the risk factors and the need ...

They can bring relief to a dog with arthritis or ... Sometimes, your vet may prescribe it along with other drugs. Amantadine. It treats nerve pain by blocking a receptor in the spinal cord.

The US Food and Drug Administration (FDA) has approved Journavx, a new pain reliever without the risks of addiction or overdose linked to drugs like Vicodin and OxyContin.

Suzetrigine, to be sold under the brand name Journavx, is the first new type of pain medicine approved by the FDA in more ...